https://www.avient.com/knowledge-base/case-study/enabling-recyclability-dairy-packaging
Some single use applications contain various layered components, making it difficult for waste facilities to effectively separate and recycle the packaging.
https://www.avient.com/company/sustainability/sustainability-report/products/markets/outdoor-high-performance-case-study
Some customers want to reduce weight but maintain strength and function, while others need protection against UV light, harsh temperatures, and other elements that might diminish product life.
https://www.avient.com/sites/default/files/2023-04/ColorMatrix UV Brochure.pdf
Direct machine dosing can
provide excellent shot-to-shot consistency
and eliminate potential mold plate-out, thus
easing processes and control.
In some situations the Ultimate UV
range can vastly improve both the processing
and mechanical properties of packaging
incorporating recycled material.
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable
indication of performance or properties obtained or obtainable on larger-scale equipment.
https://www.avient.com/sites/default/files/2020-08/wilflex-ghosting-tips-techniques.pdf
Certain things cannot be controlled by the printer:
• The dye in the shirt
• The humidity in the air and shirt
Things that can be controlled are:
• The type of ink – cotton white for cotton,
non-ghosting bleed resistant for polyester
• The amount of heat used on the garment—cure at
the recommended temp, not over
• Stack in separate piles to allow cooling—fold in
dozens separately, wait to pack
Be aware of at-risk colors; brown, tan and beige are
the most sensitive to possible ghosting.
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable
indication of performance or properties obtained or obtainable on larger-scale equipment.
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable
indication of performance or properties obtained or obtainable on larger-scale equipment.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives Chemical Foaming Agents Application Bulletin.pdf
They are
specially formulated for healthcare applications
and manufactured under controlled conditions.
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication
of performance or properties obtained or obtainable on larger-scale equipment.
Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent
implants, birth control devices, or plastic surgery.
https://www.avient.com/knowledge-base/article/understanding-hardness?rtype[]=1164
Some common materials are listed are placed on the respective hardness scale.
https://www.avient.com/investor-center/news/polyone-launches-new-specialty-technologies-k-2016-trade-show
to collaborate with many of our existing customers and to introduce some of our latest technologies to new customers also," said
https://www.avient.com/sites/default/files/2023-04/Avient_supplierFAQ.pdf
Purchase Orders
In what format will I receive now my purchase orders from Avient?
I don’t want to use Coupa Supplier Portal for submitting my invoices… what other options do I have?
What do I do if I forget my CSP password or I am locked out?
https://www.avient.com/sites/default/files/2025-04/Corporate Governance Guidelines. March 2025 - Final and Approved version.pdf
The following relationships will not be considered to be material relationships that would
impair a director’s independence:
(i) If the director is, or has an immediate family member who is, a partner (general or
limited) in, or a controlling stockholder, equity holder, executive officer, other
employee, or director of, any organization to which the Company made, or from
which the Company received, payments for property or services in the current or any
of the past three fiscal years where the amount involved in such transaction in any
such fiscal year was less than the greater of $1 million or 2% of the organization’s
consolidated gross revenues for that year;
(ii) If the director is, or has an immediate family member who is, a director or trustee of
any organization to which the Company has made, or from which the Company has
received payments for property or services, and the director (or his/her immediate
family member) was not involved in the negotiations of the terms of the transaction,
did not, to the extent applicable, provide any services directly to the Company, and
did not receive any special benefits as a result of the transaction; or
(iii) If the director, or an immediate family member of the director, serves as an officer,
director or trustee of a foundation, university, charitable or other not-for-profit
organization, and the Company’s discretionary charitable contributions to the
organization, in the aggregate are less than the greater of $1 million or 2% of that
organization’s latest publicly available annual consolidated gross revenues.
The Board administers its risk oversight function directly and through its committees.
8
The Board has delegated specific risk oversight responsibility to the committees of the
Board as follows: (i) the Audit Committee oversees risks related to the Company’s
financial statements, financial reporting processes, internal controls, information
technology, and cybersecurity; (ii) the Compensation Committee oversees risks related to
the Company’s compensation programs; (iii) the Governance and Corporate
Responsibility Committee oversees risks related to the Company’s programs, policies,
and practices related to certain sustainability and governance matters, including a review
of reports on corporate responsibility and/or sustainability published by the Company;
and (iv) the Environmental, Health and Safety Committee oversees risks related to safety,
health, physical security, environmental, and product stewardship matters.
The Board and its Committees may, in appropriate circumstances
9
and at Company expense, consult and retain independent legal, financial or other
advisors.
4.
https://www.avient.com/sites/default/files/2022-12/Mevopur Laser Marking Additives Application Bulletin.pdf
In some cases, additives are required to
achieve the desired marking quality by enabling
the plastic to absorb laser energy and/or improve
the laser marking contrast.
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication
of performance or properties obtained or obtainable on larger-scale equipment.
Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent
implants, birth control devices, or plastic surgery.